Please assess the completion status of the following clinical trial:

Trial Title: Dexmedetomidine as a Rapid Bolus in Children for Emergence Agitation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* children undergoing tonsillectomy with and without adenoidectomy and myringotomy and tube insertion~* ASA 1,2,3~* females who have started menses but have a negative urine pregnancy test~Exclusion Criteria:~* patients with known dysrhythmias,~* not recovering in the ICU~* developmental delay,~* autism communication disorder~* bleeding disorder~* PI discretion

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 10 Years
- Healthy Volunteers: f

Study Arms:
- Dexmedetomidine (Type: ACTIVE_COMPARATOR): Dexmedetomidine
- placebo (Type: PLACEBO_COMPARATOR): Normal saline

Based on this trial design, predict the completion outcome and termination type (if applicable).